Limbal stem-cell therapy and long-term corneal regeneration, N Engl J Med, vol.363, pp.147-155, 2010. ,
Treatment of severe ocular-surface disorders with corneal epithelial stem-cell transplantation, N Engl J Med, vol.340, pp.1697-1703, 1999. ,
Embryonic stem cell trials for macular degeneration: a preliminary report, Lancet, vol.379, pp.713-720, 2012. ,
Premature termination of reprogramming in vivo leads to cancer development through altered epigenetic regulation, Cell, vol.156, pp.663-677, 2014. ,
Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use, Circ Res, vol.110, pp.624-637, 2012. ,
Endothelial progenitor cells in cardiovascular disorders, J Am Coll Cardiol, vol.49, pp.741-752, 2007. ,
ABC of arterial and venous disease: acute limb ischaemia, BMJ, vol.320, pp.764-767, 2000. ,
Clinical practice. Acute limb ischemia, N Engl J Med, vol.366, pp.2198-2206, 2012. ,
Stem cell therapy for vascular regeneration: adult, embryonic, and induced pluripotent stem cells, Circulation, vol.122, pp.517-526, 2010. ,
Isolation of putative progenitor endothelial cells for angiogenesis, Science, vol.275, pp.964-967, 1997. ,
Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood, Blood, vol.104, pp.2752-2760, 2004. ,
Origins of circulating endothelial cells and endothelial outgrowth from blood, J Clin Invest, vol.105, pp.71-77, 2000. ,
Molecular analysis of endothelial progenitor cell (EPC) subtypes reveals two distinct cell populations with different identities, BMC Med Genomics, vol.3, p.18, 2010. ,
Endothelial colonyforming cell role in neoangiogenesis and tissue repair, Curr Opin Organ Transplant, vol.15, pp.68-72, 2010. ,
Genistein promotes endothelial colony-forming cell (ECFC) bioactivities and cardiac regeneration in myocardial infarction, PLoS One, vol.9, p.96155, 2014. ,
-integrin subunit plays a major role in the proangiogenic properties of endothelial progenitor cells, Arterioscler Thromb Vasc Biol, vol.30, pp.1569-1575, 2010. ,
Combination of injectable multiple growth factor-releasing scaffolds and cell therapy as an advanced modality to enhance tissue neovascularization, Arterioscler Thromb Vasc Biol, vol.30, pp.1897-1904, 2010. ,
Vascular incorporation of endothelial colony-forming cells is essential for functional recovery of murine ischemic tissue following cell therapy, Arterioscler Thromb Vasc Biol, vol.32, pp.13-21, 2012. ,
Trichostatin A enhances vascular repair by injected human endothelial progenitors through increasing the expression of TAL1-dependent genes, Cell Stem Cell, vol.14, pp.644-657, 2014. ,
URL : https://hal.archives-ouvertes.fr/inserm-02444604
Transplanted late outgrowth endothelial progenitor cells as cell therapy product for stroke, Stem Cell Rev, vol.7, pp.208-220, 2011. ,
Endothelial progenitor cell therapy for the treatment of coronary disease, acute MI, and pulmonary arterial hypertension: current perspectives, Catheter Cardiovasc Interv, vol.70, pp.983-998, 2007. ,
Outgrowth endothelial cells: characterization and their potential for reversing ischemic retinopathy, Invest Ophthalmol Vis Sci, vol.51, pp.5906-5913, 2010. ,
Existence, functional impairment, and lung repair potential of endothelial colony-forming cells in oxygen-induced arrested alveolar growth, Circulation, vol.129, pp.2144-2157, 2014. ,
Regulation of endothelial cell differentiation and specification, Circ Res, vol.112, pp.1272-1287, 2013. ,
Transcriptional regulation of endothelial cell and vascular development, Circ Res, vol.112, pp.1380-1400, 2013. ,
Transcriptional control of endothelial cell development, Dev Cell, vol.16, pp.180-195, 2009. ,
The bloody fate of endothelial stem cells, Genes Dev, vol.17, pp.322-329, 2003. ,
Key transcriptional regulators of early vascular development, Arterioscler Thromb Vasc Biol, vol.31, pp.1469-1475, 2011. ,
Specification of arterial, venous, and lymphatic endothelial cells during embryonic development, Histol Histopathol, vol.25, pp.637-646, 2010. ,
Histone deacetylase activity is essential for the expression of HoxA9 and for endothelial commitment of progenitor cells, J Exp Med, vol.201, pp.1825-1835, 2005. ,
Transcription factor Kr? uppel-like factor 2 plays a vital role in endothelial colony forming cells differentiation, Cardiovasc Res, vol.99, pp.514-524, 2013. ,
The role of chromatin during transcription, Cell, vol.128, pp.707-719, 2007. ,
Regulation of histone methylation by demethylimination and demethylation, Nat Rev Mol Cell Biol, vol.8, pp.307-318, 2007. ,
Chromatin modifications and their function, Cell, vol.128, pp.693-705, 2007. ,
Linking DNA methylation and histone modification: patterns and paradigms, Nat Rev Genet, vol.10, pp.295-304, 2009. ,
Genome-wide views of chromatin structure, Annu Rev Biochem, vol.78, pp.245-271, 2009. ,
The expression of endothelial nitric-oxide synthase is controlled by a cellspecific histone code, J Biol Chem, vol.280, pp.24824-24838, 2005. ,
Endothelial nitric oxide synthase: insight into cell-specific gene regulation in the vascular endothelium, Cell Mol Life Sci, vol.63, pp.144-162, 2006. ,
Hypoxic repression of endothelial nitric-oxide synthase transcription is coupled with eviction of promoter histones, J Biol Chem, vol.285, pp.810-826, 2010. ,
The cell-specific expression of endothelial nitric-oxide synthase: a role for DNA methylation, J Biol Chem, vol.279, pp.35087-35100, 2004. ,
Regulation of endothelial progenitor cell function by micrornas, Minerva Cardioangiol, vol.61, pp.591-604, 2013. ,
Making sense in antisense: therapeutic potential of noncoding RNAs in diabetes-induced vascular dysfunction, J Diabetes Res, p.834727, 2013. ,
Role of microRNAs in endothelial progenitor cells: implication for cardiac repair, J Stem Cells, vol.9, pp.107-115, 2014. ,
, , p.126, 2012.
, in endothelial progenitor cells from diabetes patients, impairs their functional properties, via target gene Spred-1, J Mol Cell Cardiol, vol.53, pp.64-72
microRNA 126 inhibits the transition of endothelial progenitor cells to mesenchymal cells via the PIK3R2-PI3K/Akt signalling pathway, PLoS One, vol.8, p.83294, 2013. ,
Downregulation of microRNA-130a contributes to endothelial progenitor cell dysfunction in diabetic patients via its target Runx3, PLoS One, vol.8, p.68611, 2013. ,
MicroRNA-130a regulates autophagy of endothelial progenitor cells through Runx3, Clin Exp Pharmacol Physiol, vol.41, pp.351-357, 2014. ,
MicroRNA-10A* and MicroRNA-21 modulate endothelial progenitor cell senescence via suppressing high-mobility group A2, Circ Res, vol.112, pp.152-164, 2013. ,
) miRNome traits analysis on endothelial lineage cells discloses biomarker potential circulating microRNAs which affect progenitor activities, BMC Genom, vol.15, 2014. ,
Noncoding RNAs as regulators of gene expression and epigenetics, Cardiovasc Res, vol.90, pp.430-440, 2011. ,
Post-transcriptional regulation of endothelial nitric-oxide synthase by an overlapping antisense mRNA transcript, J Biol Chem, vol.279, pp.37982-37996, 2004. ,
Hypoxiainducible expression of a natural cis-antisense transcript inhibits endothelial nitric-oxide synthase, J Biol Chem, vol.282, pp.15652-15666, 2007. ,
A noncoding antisense RNA in tie-1 locus regulates tie-1 function in vivo, Blood, vol.115, pp.133-139, 2010. ,
Epigenetics of the vascular endothelium, J Appl Physiol, vol.109, pp.916-926, 1985. ,
TET enzymes, TDG and the dynamics of DNA demethylation, Nature, vol.502, pp.472-479, 2013. ,
DNA methyltransferase inhibition induces mouse embryonic stem cell differentiation into endothelial cells, Exp Cell Res, vol.316, pp.172-180, 2010. ,
A mechanistic role for DNA methylation in endothelial cell (EC)-enriched gene expression: relationship with DNA replication timing, Blood, vol.121, pp.3531-3540, 2013. ,
Efficient differentiation of hESCs into endothelial cells in vitro is secured by epigenetic changes, Cell Cycle, vol.7, pp.2929-2935, 2008. ,
Induction of pluripotency in human endothelial cells resets epigenetic profile on genome scale, Cell Cycle, vol.9, pp.937-946, 2010. ,
Epigenetic regulation of endothelial lineage committed genes in pro-angiogenic hematopoietic and endothelial progenitor cells, Zeiher AM & Dimmeler S, vol.109, pp.1219-1229, 2011. ,
Histone deacetylase inhibitors: potential in cancer therapy, J Cell Biochem, vol.107, pp.600-608, 2009. ,
Histone deacetylase inhibitors: a chemical genetics approach to understanding cellular functions, Biochim Biophys Acta, vol.1799, pp.717-725, 2010. ,
Histone acetyltransferases, Annu Rev Biochem, vol.70, pp.81-120, 2001. ,
Chemical mechanisms of histone lysine and arginine modifications, Biochim Biophys Acta, vol.1789, pp.45-57, 2009. ,
Roles of histone acetyltransferases and deacetylases in gene regulation, BioEssays, vol.20, pp.615-626, 1998. ,
The human histone deacetylase family, Exp Cell Res, vol.262, pp.75-83, 2001. ,
, , 2011.
, Acetylation-dependent regulation of endothelial Notch signalling by the SIRT1 deacetylase, Nature, vol.473, pp.234-238
Emerging roles of SIRT1 in vascular endothelial homeostasis, Cell Cycle, vol.7, pp.2117-2122, 2008. ,
Histone deacetylases (HDACs): characterization of the classical HDAC family, Biochem J, vol.370, pp.737-749, 2003. ,
Anticancer activities of histone deacetylase inhibitors, Nat Rev Drug Discov, vol.5, pp.769-784, 2006. ,
Duration of nuclear NF-kappaB action regulated by reversible acetylation, Science, vol.293, pp.1653-1657, 2001. ,
Inhibition of histone deacetylase protects the retina from ischemic injury, Invest Ophthalmol Vis Sci, vol.51, pp.3639-3645, 2010. ,
Valproic acid-mediated neuroprotection in retinal ischemia injury via histone deacetylase inhibition and transcriptional activation, Exp Eye Res, vol.94, pp.98-108, 2012. ,
Histone deacetylase inhibition reduces myocardial ischemiareperfusion injury in mice, FASEB J, vol.22, pp.3549-3560, 2008. ,
Epigenetic histone modification and cardiovascular lineage programming in mouse embryonic stem cells exposed to laminar shear stress, Circ Res, vol.96, pp.501-508, 2005. ,
Activation of p300 histone acetyltransferase activity is an early endothelial response to laminar shear stress and is essential for stimulation of endothelial nitricoxide synthase mRNA transcription, J Biol Chem, vol.283, pp.16293-16298, 2008. ,
Diabetes-induced extracellular matrix protein expression is mediated by transcription coactivator p300, Diabetes, vol.55, pp.3104-3111, 2006. ,
Quantitative control of adaptive cardiac hypertrophy by acetyltransferase p300, Circulation, vol.118, pp.934-946, 2008. ,
MicroRNA-20a constrains p300-driven myocardial angiogenic transcription by direct targeting of p300, PLoS One, vol.8, p.79133, 2013. ,
An essential role for p300/CBP in the cellular response to hypoxia, Proc Natl Acad Sci, vol.93, pp.12969-12973, 1996. ,
Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives, Physiol Rev, vol.91, pp.327-387, 2011. ,
Mechanotransduction in vascular physiology and atherogenesis, Nat Rev Mol Cell Biol, vol.10, pp.53-62, 2009. ,
Vascular endothelial responses to altered shear stress: pathologic implications for atherosclerosis, Ann Med, vol.41, pp.19-28, 2009. ,
Laminar shear stress: mechanisms by which endothelial cells transduce an atheroprotective force, Arterioscler Thromb Vasc Biol, vol.18, pp.677-685, 1998. ,
Role of histone deacetylases in transcription factor regulation and cell cycle modulation in endothelial cells in response to disturbed flow, Proc Natl Acad Sci, vol.109, pp.1967-1972, 2012. ,
Role of histone deacetylation in cellspecific expression of endothelial nitric-oxide synthase, J Biol Chem, vol.280, pp.16467-16475, 2005. ,
Histone deacetylase 1 reduces NO production in endothelial cells via lysine deacetylation of NO synthase 3, Am J Physiol Heart Circ Physiol, vol.307, p.5, 2014. ,
Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase, J Clin Invest, vol.90, pp.2092-2096, 1992. ,
Signal transduction of eNOS activation, Cardiovasc Res, vol.43, pp.532-541, 1999. ,
The role of p53 deacetylation in p21Waf1 regulation by laminar flow, J Biol Chem, vol.278, pp.24594-24599, 2003. ,
Transcriptional regulation of endothelial arginase 2 by histone deacetylase 2, Arterioscler Thromb Vasc Biol, vol.34, pp.1556-1566, 2014. ,
Inhibition of HDAC2 protects the retina from ischemic injury, Invest Ophthalmol Vis Sci, vol.54, pp.4072-4080, 2013. ,
Sca-1+ progenitors derived from embryonic stem cells differentiate into endothelial cells capable of vascular repair after arterial injury, Arterioscler Thromb Vasc Biol, vol.26, pp.2244-2251, 2006. ,
HDAC3 is crucial in shear-and VEGF-induced stem cell differentiation toward endothelial cells, J Cell Biol, vol.174, pp.1059-1069, 2006. ,
Histone deacetylase 3 is critical in endothelial survival and atherosclerosis development in response to disturbed flow, Circulation, vol.121, pp.132-142, 2010. ,
Histone deacetylase 3 unconventional splicing mediates endothelial-to-mesenchymal transition through transforming growth factor b2, J Biol Chem, vol.288, pp.31853-31866, 2013. ,
Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development, Mol Cell Biol, vol.24, pp.8467-8476, 2004. ,
Histone deacetylase 7 maintains vascular integrity by repressing matrix metalloproteinase 10, Cell, vol.126, pp.321-334, 2006. ,
Control of endothelial cell proliferation and migration by VEGF signaling to histone deacetylase 7, Proc Natl Acad Sci, vol.105, pp.7738-7743, 2008. ,
HDAC4 represses vascular endothelial growth factor expression in chondrosarcoma by modulating RUNX2 activity, J Biol Chem, vol.284, pp.21881-21890, 2009. ,
HDAC5 is a repressor of angiogenesis and determines the angiogenic gene expression pattern of endothelial cells, Blood, vol.113, pp.5669-5679, 2009. ,
Protein kinase D-dependent phosphorylation and nuclear export of histone deacetylase 5 mediates vascular endothelial growth factor-induced gene expression and angiogenesis, J Biol Chem, vol.283, pp.14590-14599, 2008. ,
Histone deacetylase 5 interacts with Kr? uppel-like factor 2 and inhibits its transcriptional activity in endothelium, Cardiovasc Res, vol.104, pp.127-137, 2014. ,
Nitric oxide modulates chromatin folding in human endothelial cells via protein phosphatase 2A activation and class II histone deacetylases nuclear shuttling, Circ Res, vol.102, pp.51-58, 2008. ,
Histone deacetylase 7 silencing alters endothelial cell migration, a key step in angiogenesis, Circ Res, vol.101, pp.1237-1246, 2007. ,
The angiogenesis suppressor gene AKAP12 is under the epigenetic control of HDAC7 in endothelial cells, Angiogenesis, vol.15, pp.543-554, 2012. ,
Histone deacetylase 7 controls endothelial cell growth through modulation of betacatenin, Circ Res, vol.106, pp.1202-1211, 2010. ,
Splicing of HDAC7 modulates the SRF-myocardin complex during stem-cell differentiation towards smooth muscle cells, J Cell Sci, vol.122, pp.460-470, 2009. ,
VEGF stimulates HDAC7 phosphorylation and cytoplasmic accumulation modulating matrix metalloproteinase expression and angiogenesis, Arterioscler Thromb Vasc Biol, vol.28, pp.1782-1788, 2008. ,
VEGF-PKD1-HDAC7 signaling promotes endothelial progenitor cell migration and tube formation, Microvasc Res, vol.91, pp.66-72, 2014. ,
Histone deacetylase 9 promotes angiogenesis by targeting the antiangiogenic microRNA-17-92 cluster in endothelial cells, Arterioscler Thromb Vasc Biol, vol.33, pp.533-543, 2013. ,
Class IIb HDAC6 regulates endothelial cell migration and angiogenesis by deacetylation of cortactin, EMBO J, vol.30, pp.4142-4156, 2011. ,
SIRT1 controls endothelial angiogenic functions during vascular growth, Genes Dev, vol.21, pp.2644-2658, 2007. ,
SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase, Proc Natl Acad Sci, vol.104, pp.14855-14860, 2007. ,
Early apoptotic vascular signaling is determined by Sirt1 through nuclear shuttling, forkhead trafficking, bad, and mitochondrial caspase activation, Curr Neurovasc Res, vol.7, pp.95-112, 2010. ,
SIRT1 promotes proliferation and prevents senescence through targeting LKB1 in primary porcine aortic endothelial cells, Circ Res, vol.106, pp.1384-1393, 2010. ,
Accelerated senescence of cord blood endothelial progenitor cells in premature neonates is driven by SIRT1 decreased expression, Blood, vol.123, pp.2116-2126, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01666068
Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease, Genes Dev, vol.22, pp.1115-1140, 2008. ,
Charting histone modifications and the functional organization of mammalian genomes, Nat Rev Genet, vol.12, pp.7-18, 2011. ,
Modification of enhancer chromatin: what, how, and why?, Mol Cell, vol.49, pp.825-837, 2013. ,
A bivalent chromatin structure marks key developmental genes in embryonic stem cells, Cell, vol.125, pp.315-326, 2006. ,
A unique chromatin signature uncovers early developmental enhancers in humans, Nature, vol.470, pp.279-283, 2011. ,
Transcriptional and epigenetic dynamics during specification of human embryonic stem cells, Cell, vol.153, pp.1149-1163, 2013. ,
A double take on bivalent promoters, Genes Dev, vol.27, pp.1318-1338, 2013. ,
Histone lysine methylation and demethylation pathways in cancer, Biochim Biophys Acta, vol.1815, pp.75-89, 2011. ,
Histone H3 lysine 4 (H3K4) methylation in development and differentiation, Dev Biol, vol.339, pp.240-249, 2010. ,
WRAD: enabler of the SET1-family of H3K4 methyltransferases, Brief Funct Genomics, vol.11, pp.217-226, 2012. ,
An Mll-dependent Hox program drives hematopoietic progenitor expansion, Curr Biol, vol.14, pp.2063-2069, 2004. ,
Definitive hematopoiesis requires the mixed-lineage leukemia gene, Dev Cell, vol.6, pp.437-443, 2004. ,
Defects in yolk sac hematopoiesis in Mll-null embryos, Blood, vol.90, pp.1799-1806, 1997. ,
The histone methyltransferase MLL is an upstream regulator of endothelial-cell sprout formation, Blood, vol.109, pp.1472-1478, 2007. ,
Binding of the JmjC demethylase JARID1B to LSD1/NuRD suppresses angiogenesis and metastasis in breast cancer cells by repressing chemokine CCL14, Cancer Res, vol.71, pp.6899-6908, 2011. ,
Histone demethylase LSD1 deficiency during high-salt diet is associated with enhanced vascular contraction, altered NO-cGMP relaxation pathway, and hypertension, Am J Physiol Heart Circ Physiol, vol.301, pp.1862-1871, 2011. ,
Chromatin remodeling and cancer. Part I: Covalent histone modifications, Trends Mol Med, vol.13, pp.363-372, 2007. ,
Histone lysine methylation dynamics: establishment, regulation, and biological impact, Mol Cell, vol.48, pp.491-507, 2012. ,
Gene-specific targeting of H3K9 methylation is sufficient for initiating repression in vivo, Curr Biol, vol.12, pp.2159-2166, 2002. ,
The polycomb group protein EZH2 is involved in progression of prostate cancer, Nature, vol.419, pp.624-629, 2002. ,
EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells, Proc Natl Acad Sci, vol.100, pp.11606-11611, 2003. ,
Importance of Ezh2 polycomb protein in tumorigenesis process interfering with the pathway of growth suppressive key elements, J Cell Physiol, vol.214, pp.295-300, 2008. ,
EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation, Proc Natl Acad Sci, vol.106, pp.5324-5329, 2009. ,
Regulation of tumor angiogenesis by EZH2, Cancer Cell, vol.18, pp.185-197, 2010. ,
Downregulation of miR-101 in endothelial cells promotes blood vessel formation through reduced repression of EZH2, PLoS One, vol.6, p.16282, 2011. ,
Epigenetic regulation of cell adhesion and communication by enhancer of zeste homolog 2 in human endothelial cells, Hypertension, vol.60, pp.1176-1183, 2012. ,
EZH2 modulates angiogenesis in vitro and in a mouse model of limb ischemia, Mol Ther, vol.23, pp.32-42, 2015. ,
Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes, Nature, vol.463, pp.360-363, 2010. ,
UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development, Nature, vol.449, pp.731-734, 2007. ,
Cloning and functional analysis of cDNAs with open reading frames for 300 previously undefined genes expressed in CD34+ hematopoietic stem/progenitor cells, Genome Res, vol.10, pp.1546-1560, 2000. ,
, , 2010.
, Histone H3 lysine 36 methyltransferase Hypb/Setd2 is required for embryonic vascular remodeling, Proc Natl Acad Sci, vol.107, pp.2956-2961
Azacitidine in the management of patients with myelodysplastic syndromes, Ther Adv Hematol, vol.3, pp.355-373, 2012. ,
Concise drug review: azacitidine and decitabine, Oncologist, vol.18, pp.619-624, 2013. ,
Development and classes of epigenetic drugs for cancer, Biochem Biophys Res Commun, vol.455, pp.58-69, 2014. ,
Vascular histone deacetylation by pharmacological HDAC inhibition, Genome Res, vol.24, pp.1271-1284, 2014. ,
Histone deacetylase (HDAC) inhibitors down-regulate endothelial lineage commitment of umbilical cord blood derived endothelial progenitor cells, Int J Mol Sci, vol.13, pp.15074-15085, 2012. ,
, , 2002.
, Inhibitors of histone deacetylation downregulate the expression of endothelial nitric oxide synthase and compromise endothelial cell function in vasorelaxation and angiogenesis, Circ Res, vol.91, pp.837-844
Dual effects of histone deacetylase inhibition by trichostatin A on endothelial nitric oxide synthase expression in endothelial cells, Biochem Biophys Res Commun, vol.340, pp.29-34, 2006. ,
Next generation histone deacetylase inhibitors: the answer to the search for optimized epigenetic therapies?, Expert Opin Drug Discov, vol.6, pp.393-404, 2011. ,
HIF-1a of bone marrow endothelial cells implies relapse and drug resistance in patients with multiple myeloma and may act as a therapeutic target, Clin Cancer Res, vol.20, pp.847-858, 2014. ,
Valproic acid inhibits angiogenesis in vitro and in vivo, Mol Pharmacol, vol.65, pp.520-527, 2004. ,
Valproic acid induces extracellular signal-regulated kinase 1/2 activation and inhibits apoptosis in endothelial cells, Cell Death Differ, vol.13, pp.446-453, 2006. ,
Histone deacetylase inhibitors: overview and perspectives, Mol Cancer Res, vol.5, pp.981-989, 2007. ,
Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications, Chem Biol, vol.13, pp.563-567, 2006. ,
Analysis of the levels of lysine-specific demethylase 1 (LSD1) mRNA in human ovarian tumors and the effects of chemical LSD1 inhibitors in ovarian cancer cell lines, J Ovarian Res, vol.6, p.75, 2013. ,
Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-transretinoic acid differentiation pathway in acute myeloid leukemia, Nat Med, vol.18, pp.605-611, 2012. ,
Lysinespecific demethylase 1 is a therapeutic target for fetal hemoglobin induction, Nat Med, vol.19, pp.291-294, 2013. ,
3-Deazaneplanocin: a new and potent inhibitor of S-adenosylhomocysteine hydrolase and its effects on human promyelocytic leukemia cell line HL-60, 1986. ,
, Biochem Biophys Res Commun, vol.135, pp.688-694
Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells, Genes Dev, vol.21, pp.1050-1063, 2007. ,
DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation, Mol Cancer Ther, vol.8, pp.1579-1588, 2009. ,
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations, Nature, vol.492, pp.108-112, 2012. ,
Identification of potent, selective, cell-active inhibitors of the histone lysine methyltransferase EZH2, ACS Med Chem Lett, vol.3, pp.1091-1096, 2012. ,
A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells, Nat Chem Biol, vol.8, pp.890-896, 2012. ,
Threedimensional culture sensitizes epithelial ovarian cancer cells to EZH2 methyltransferase inhibition, Cell Cycle, vol.12, pp.2113-2119, 2013. ,
EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation, Cancer Cell, vol.23, pp.677-692, 2013. ,
The histone H3 lysine 9 methyltransferases G9a and GLP regulate polycomb repressive complex 2-mediated gene silencing, Mol Cell, vol.53, pp.277-289, 2014. ,
Synergistic re-activation of epigenetically silenced genes by combinatorial inhibition of DNMTs and LSD1 in cancer cells, PLoS One, vol.8, p.75136, 2013. ,
Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells, Leukemia, vol.28, pp.2155-2164, 2014. ,